NASDAQ:BOWX

BowX Acquisition Competitors

$12.99
+0.22 (+1.72 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$12.18
Now: $12.99
$13.65
50-Day Range
$9.74
MA: $10.86
$13.71
52-Week Range
$9.65
Now: $12.99
$13.93
Volume1.87 million shs
Average Volume1.34 million shs
Market Capitalization$784.27 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

BowX Acquisition (NASDAQ:BOWX) Vs. AJAX, AJAX, BTWN, CMLF, TPGY, and BOAC

Should you be buying BOWX stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to BowX Acquisition, including Ajax I (AJAX), Ajax I (AJAX), Bridgetown (BTWN), CM Life Sciences (CMLF), TPG Pace Beneficial Finance (TPGY), and Bluescape Opportunities Acquisition (BOAC).

BowX Acquisition (NASDAQ:BOWX) and Ajax I (NYSE:AJAX) are both small-cap unclassified companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, valuation, analyst recommendations, dividends and institutional ownership.

Earnings & Valuation

This table compares BowX Acquisition and Ajax I's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BowX AcquisitionN/AN/AN/AN/AN/A
Ajax IN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations for BowX Acquisition and Ajax I, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BowX Acquisition0000N/A
Ajax I0000N/A

Profitability

This table compares BowX Acquisition and Ajax I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BowX AcquisitionN/AN/AN/A
Ajax IN/AN/AN/A

BowX Acquisition (NASDAQ:BOWX) and Ajax I (NYSE:AJAX) are both small-cap unclassified companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Analyst Ratings

This is a summary of current ratings and target prices for BowX Acquisition and Ajax I, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BowX Acquisition0000N/A
Ajax I0000N/A

Profitability

This table compares BowX Acquisition and Ajax I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BowX AcquisitionN/AN/AN/A
Ajax IN/AN/AN/A

Earnings and Valuation

This table compares BowX Acquisition and Ajax I's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BowX AcquisitionN/AN/AN/AN/AN/A
Ajax IN/AN/AN/AN/AN/A

Bridgetown (NASDAQ:BTWN) and BowX Acquisition (NASDAQ:BOWX) are both small-cap unclassified companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations.

Earnings and Valuation

This table compares Bridgetown and BowX Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BridgetownN/AN/AN/AN/AN/A
BowX AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares Bridgetown and BowX Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BridgetownN/AN/AN/A
BowX AcquisitionN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations for Bridgetown and BowX Acquisition, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bridgetown0000N/A
BowX Acquisition0000N/A

CM Life Sciences (NASDAQ:CMLF) and BowX Acquisition (NASDAQ:BOWX) are both small-cap financial services companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Profitability

This table compares CM Life Sciences and BowX Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CM Life SciencesN/AN/AN/A
BowX AcquisitionN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for CM Life Sciences and BowX Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CM Life Sciences0000N/A
BowX Acquisition0000N/A

Earnings & Valuation

This table compares CM Life Sciences and BowX Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CM Life SciencesN/AN/AN/AN/AN/A
BowX AcquisitionN/AN/AN/AN/AN/A

TPG Pace Beneficial Finance (NYSE:TPGY) and BowX Acquisition (NASDAQ:BOWX) are both small-cap financial services companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation and earnings.

Analyst Ratings

This is a summary of recent ratings and recommmendations for TPG Pace Beneficial Finance and BowX Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
TPG Pace Beneficial Finance0000N/A
BowX Acquisition0000N/A

Profitability

This table compares TPG Pace Beneficial Finance and BowX Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
TPG Pace Beneficial FinanceN/AN/AN/A
BowX AcquisitionN/AN/AN/A

Valuation & Earnings

This table compares TPG Pace Beneficial Finance and BowX Acquisition's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TPG Pace Beneficial FinanceN/AN/AN/AN/AN/A
BowX AcquisitionN/AN/AN/AN/AN/A

Bluescape Opportunities Acquisition (NYSE:BOAC) and BowX Acquisition (NASDAQ:BOWX) are both small-cap unclassified companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, risk, earnings, profitability, valuation, dividends and institutional ownership.

Analyst Ratings

This is a summary of current ratings and target prices for Bluescape Opportunities Acquisition and BowX Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bluescape Opportunities Acquisition0000N/A
BowX Acquisition0000N/A

Profitability

This table compares Bluescape Opportunities Acquisition and BowX Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bluescape Opportunities AcquisitionN/AN/AN/A
BowX AcquisitionN/AN/AN/A

Valuation and Earnings

This table compares Bluescape Opportunities Acquisition and BowX Acquisition's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A
BowX AcquisitionN/AN/AN/AN/AN/A


BowX Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ajax I logo
AJAX
Ajax I
0.0$10.22+1.1%$914.11 millionN/A0.00News Coverage
Ajax I logo
AJAX
Ajax I
0.0$10.22+1.1%$914.11 millionN/A0.00News Coverage
BTWN
Bridgetown
0.0$11.83+2.4%$879.84 millionN/A0.00
CMLF
CM Life Sciences
0.0$15.00+2.9%$830.16 millionN/A0.00Gap Down
TPGY
TPG Pace Beneficial Finance
0.3$18.10+2.5%$791.88 millionN/A0.00
BOAC
Bluescape Opportunities Acquisition
0.0$10.15+2.1%$770.77 millionN/A0.00High Trading Volume
VYGG
Vy Global Growth
0.0$10.20+0.3%$733.13 millionN/A0.00
HZON
Horizon Acquisition Co. II
0.0$10.31+0.1%$683.49 millionN/A0.00
LCY
Landcadia Holdings III
1.7$10.41+0.9%$670.14 millionN/A0.00
ACIC
Atlas Crest Investment
0.0$10.21+1.9%$638.13 millionN/A0.00
VSPR
Vesper Healthcare Acquisition
1.7$10.60+2.0%$609.50 millionN/A0.00
MIT
Mason Industrial Technology
0.0$9.75+0.6%$609.38 millionN/A0.00
HAAC
Health Assurance Acquisition
0.0$10.70+0.7%$592.51 millionN/A0.00
KVSC
Khosla Ventures Acquisition Co. III
0.0$10.15+0.8%$571.45 millionN/A0.00News Coverage
VAQC
Vector Acquisition Corp II
0.0$9.95+0.1%$570.63 millionN/A0.00News Coverage
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$10.02+0.0%$563.63 millionN/A0.00News Coverage
CFII
CF Finance Acquisition Corp. II
0.3$8.21+1.2%$522.16 millionN/A0.00Gap Down
MOTV
Motive Capital
0.0$10.04+0.9%$519.57 millionN/A0.00
MAAC
Montes Archimedes Acquisition
0.0$9.83+0.0%$516.78 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.0$9.95+0.2%$514.91 millionN/A0.00
DGNU
ArcLight Clean Transition Corp. II Unit
0.0$10.26+1.0%$513 millionN/A0.00
SPNV
Supernova Partners Acquisition
0.0$10.06+0.2%$506.15 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$9.98+0.1%$502.12 millionN/A0.00High Trading Volume
GMII
Gores Metropoulos II
0.0$10.04+1.0%$502 millionN/A0.00High Trading Volume
News Coverage
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.80+0.1%$501.63 millionN/A0.00
EPHY
Epiphany Technology Acquisition
0.0$9.80+0.3%$500.90 millionN/A0.00
AGCB
Altimeter Growth Corp. 2
0.3$11.06+0.1%$497.70 millionN/A0.00
KVSB
Khosla Ventures Acquisition Co. II
0.0$10.24+0.5%$472.06 millionN/A0.00
GHVI
Gores Holdings VI
0.0$13.64+1.3%$470.58 millionN/A0.00
NGAC
NextGen Acquisition
0.0$9.99+0.1%$468.28 millionN/A0.00
SPFR
Jaws Spitfire Acquisition
0.0$10.70+0.1%$461.44 millionN/A0.00High Trading Volume
HIGA
H.I.G. Acquisition
0.0$10.01+0.2%$457.84 millionN/A0.00
LUXA
Lux Health Tech Acquisition
0.0$10.42+0.2%$449.36 millionN/A0.00Unusual Options Activity
News Coverage
RMGB
RMG Acquisition Co. II
0.0$10.07+0.5%$434.27 millionN/A0.00
FSRV
FinServ Acquisition
0.0$13.55+8.2%$432.45 millionN/A0.00Gap Up
CAP
Capitol Investment Corp. V
0.0$9.98+0.2%$430.39 millionN/A0.00
MUDS
Mudrick Capital Acquisition Co. II
0.0$10.85+1.5%$428.91 millionN/A0.00High Trading Volume
News Coverage
GFX
Golden Falcon Acquisition
0.0$9.86+0.1%$425.21 millionN/A0.00
PCPC
Periphas Capital Partnering
0.0$24.60+1.5%$413.43 millionN/A0.00High Trading Volume
Gap Up
HOL
Holicity
0.0$10.76+1.0%$403.50 millionN/A0.00Unusual Options Activity
News Coverage
NSTB
Northern Star Investment Corp. II
0.0$10.08+0.6%$403.20 millionN/A0.00
PIAI
Prime Impact Acquisition I
0.0$9.91+0.0%$401.46 millionN/A0.00
TSIA
TS Innovation Acquisitions
0.0$10.62+2.9%$398.25 millionN/A0.00News Coverage
Gap Down
RAAC
Revolution Acceleration Acquisition
0.0$10.29+0.2%$394.45 millionN/A0.00
XPOA
DPCM Capital
0.0$10.01+0.8%$386.64 millionN/A0.00
KVSA
Khosla Ventures Acquisition
0.0$10.45+1.0%$375.16 millionN/A0.00Quiet Period Expiration
IGAC
IG Acquisition
0.0$9.98+0.2%$374.25 millionN/A0.00
PRSR
Prospector Capital
0.0$9.86+0.4%$369.75 millionN/A0.00
GMBT
Queen's Gambit Growth Capital
0.0$9.86+0.1%$369.75 millionN/A0.00
VIH
VPC Impact Acquisition
0.3$14.25+3.9%$369.39 millionN/A0.00News Coverage
Gap Down
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.